Annual CFF
$696.00 K
-$205.00 K-22.75%
December 31, 2023
Summary
- As of February 8, 2025, OMIC annual cash flow from financing activities is $696.00 thousand, with the most recent change of -$205.00 thousand (-22.75%) on December 31, 2023.
- During the last 3 years, OMIC annual CFF has fallen by -$6.82 million (-90.74%).
- OMIC annual CFF is now -99.81% below its all-time high of $372.13 million, reached on December 31, 2021.
Performance
OMIC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$80.00 K-100.00%
September 30, 2024
Summary
- As of February 8, 2025, OMIC quarterly cash flow from financing activities is $0.00, with the most recent change of -$80.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, OMIC quarterly CFF has dropped by -$72.00 thousand (-100.00%).
- OMIC quarterly CFF is now -100.00% below its all-time high of $239.15 million, reached on June 30, 2021.
Performance
OMIC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$152.00 K
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, OMIC TTM cash flow from financing activities is $152.00 thousand, unchanged on September 30, 2024.
- Over the past year, OMIC TTM CFF has dropped by -$544.00 thousand (-78.16%).
- OMIC TTM CFF is now -99.96% below its all-time high of $372.64 million, reached on June 30, 2021.
Performance
OMIC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
OMIC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.8% | -100.0% | -78.2% |
| 3 y3 years | -90.7% | -100.0% | -78.2% |
| 5 y5 years | -98.5% | -100.0% | -78.2% |
OMIC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.8% | at low | -100.0% | at low | -100.0% | +139.4% |
| 5 y | 5-year | -99.8% | at low | -100.0% | +100.0% | -100.0% | +139.4% |
| alltime | all time | -99.8% | at low | -100.0% | +100.0% | -100.0% | +139.4% |
Singular Genomics Systems Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $152.00 K(0.0%) |
| Jun 2024 | - | $80.00 K(>+9900.0%) | $152.00 K(-78.0%) |
| Mar 2024 | - | $0.00(-100.0%) | $690.00 K(-0.9%) |
| Dec 2023 | $696.00 K(-22.8%) | $72.00 K(>+9900.0%) | $696.00 K(-49.3%) |
| Sep 2023 | - | $0.00(-100.0%) | $1.37 M(-1.9%) |
| Jun 2023 | - | $618.00 K(>+9900.0%) | $1.40 M(+58.5%) |
| Mar 2023 | - | $6000.00(-99.2%) | $884.00 K(-1.9%) |
| Dec 2022 | $901.00 K | $750.00 K(+2677.8%) | $901.00 K(-6.2%) |
| Sep 2022 | - | $27.00 K(-73.3%) | $961.00 K(-349.0%) |
| Jun 2022 | - | $101.00 K(+339.1%) | -$386.00 K(-100.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $23.00 K(-97.2%) | $238.67 M(-35.9%) |
| Dec 2021 | $372.13 M(+4851.8%) | $810.00 K(-161.4%) | $372.13 M(+0.2%) |
| Sep 2021 | - | -$1.32 M(-100.6%) | $371.35 M(-0.3%) |
| Jun 2021 | - | $239.15 M(+79.2%) | $372.64 M(+179.2%) |
| Mar 2021 | - | $133.48 M(>+9900.0%) | $133.49 M(+1676.3%) |
| Dec 2020 | $7.51 M(-84.1%) | $28.00 K(-221.7%) | $7.51 M(+0.4%) |
| Sep 2020 | - | -$23.00 K(<-9900.0%) | $7.49 M(-0.3%) |
| Jun 2020 | - | $0.00(-100.0%) | $7.51 M(0.0%) |
| Mar 2020 | - | $7.51 M | $7.51 M |
| Dec 2019 | $47.30 M | - | - |
FAQ
- What is Singular Genomics Systems annual cash flow from financing activities?
- What is the all time high annual CFF for Singular Genomics Systems?
- What is Singular Genomics Systems annual CFF year-on-year change?
- What is Singular Genomics Systems quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Singular Genomics Systems?
- What is Singular Genomics Systems quarterly CFF year-on-year change?
- What is Singular Genomics Systems TTM cash flow from financing activities?
- What is the all time high TTM CFF for Singular Genomics Systems?
- What is Singular Genomics Systems TTM CFF year-on-year change?
What is Singular Genomics Systems annual cash flow from financing activities?
The current annual CFF of OMIC is $696.00 K
What is the all time high annual CFF for Singular Genomics Systems?
Singular Genomics Systems all-time high annual cash flow from financing activities is $372.13 M
What is Singular Genomics Systems annual CFF year-on-year change?
Over the past year, OMIC annual cash flow from financing activities has changed by -$205.00 K (-22.75%)
What is Singular Genomics Systems quarterly cash flow from financing activities?
The current quarterly CFF of OMIC is $0.00
What is the all time high quarterly CFF for Singular Genomics Systems?
Singular Genomics Systems all-time high quarterly cash flow from financing activities is $239.15 M
What is Singular Genomics Systems quarterly CFF year-on-year change?
Over the past year, OMIC quarterly cash flow from financing activities has changed by -$72.00 K (-100.00%)
What is Singular Genomics Systems TTM cash flow from financing activities?
The current TTM CFF of OMIC is $152.00 K
What is the all time high TTM CFF for Singular Genomics Systems?
Singular Genomics Systems all-time high TTM cash flow from financing activities is $372.64 M
What is Singular Genomics Systems TTM CFF year-on-year change?
Over the past year, OMIC TTM cash flow from financing activities has changed by -$544.00 K (-78.16%)